NorthRock Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,384
Closed -$427K 849
2025
Q3
$427K Buy
1,384
+281
+25% +$88K 0.01% 583
2025
Q2
$347K Buy
1,103
+132
+14% +$38.1K 0.01% 503
2025
Q1
$255K Sell
971
-50
-5% -$13.5K 0.01% 505
2024
Q4
$267K Sell
1,021
-2
-0.2% -$504 0.01% 506
2024
Q3
$238K Sell
1,023
-77
-7% -$15.8K 0.01% 566
2024
Q2
$222K Buy
+1,100
New +$198K 0.01% 547

Other funds holding PODD

NorthRock Partners's PODD Position: Q4 2025 in Review

NorthRock Partners sold out of Insulet (PODD) in Q4 2025, closing a stake of 1,384 shares — an estimated $427K sold.

NorthRock Partners first reported a position in PODD in Q2 2024 and held it in 6 quarters. The position peaked at $427K in Q3 2025. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • NorthRock Partners reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 1,384 Insulet shares in Q4 2025, an estimated $427K.
  • NorthRock Partners first reported a position in Insulet in Q2 2024 and held it in 6 quarters.
  • NorthRock Partners's Insulet position peaked at $427K in Q3 2025.
  • 832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.